Especiação química do V(V) e W(VI) na presença de ácidos (amino)-hidroxâmicos em meio aquoso

=== A variety of hydroxamic acids and their derivatives have been reported to have pharmacological activities toward cancer and cardiovascular diseases. Besides presenting insulin-mimetic activity, they have also been reported to be active as cellular division inhibitors. Supposedly, these characte...

Full description

Bibliographic Details
Main Author: Cristiano Torres Miranda
Other Authors: Vito Modesto de Bellis
Format: Others
Language:Portuguese
Published: Universidade Federal de Minas Gerais 2010
Online Access:http://hdl.handle.net/1843/SFSA-88GQ3P
Description
Summary:=== A variety of hydroxamic acids and their derivatives have been reported to have pharmacological activities toward cancer and cardiovascular diseases. Besides presenting insulin-mimetic activity, they have also been reported to be active as cellular division inhibitors. Supposedly, these characteristics are related to their great ability to coordinate several metal ions through the CONHOH group, a subject that has attracted considerable interest in recent years. At the same time, vanadium(V) and tungsten(VI) salts have also been found to have insulin-mimetic properties. However their use is not recommended since they are unable to survive to pH changes and redox reactions. These compounds therefore lose their pharmacological characteristics and become unsuitable as oral substitutes for insulin. Hydroxamic acids are a class of ligands capable of forming complexes with both vanadium(V) or tungsten(VI) ions, therefore reducing their toxicity and, at the same time, improving their pharmacological properties. The full specification of complexes of vanadium(V) with glycinehydroxamic acid and three -aminohydroxamic acids (-alanine-, -threonine- and -lysine) has been achieved using potentiometrical and spectroscopical techniques. Formation constants were calculating in a systematical study at different concentrations and ligand-to-metal molar ratios. In each case, in a neutral medium, two complexes were identifying with 1:1 and 1:2 metal-to-ligand ratios, both of which can either be protonated or deprotonated depending on the acidity or basicity of the medium. Structures of the several complexes were proposed based on 51V NMR results. The 1:1 complex, VO2L (VO2+=dioxovanadium(V) ion and L-= -aminohydroxamic acid), has a distorted trigonal bipiramidal structure in neutral medium and it exists as VO2HL+ in acidic and as VO2(OH)L- in basic medium. The 1:2 complex, VO2H2L2+, which is formed in neutral medium, has an octahedral structure and also exists as VO2H3L2 2+ and VO2HL2+, in acidic and basic media, respectively. In all cases, only the hydroxamate group appears to be coordinated to the VO2 + group. Exploring different coordination possibilities that are available in hydroxamic acids, the complexation of vanadium(V) with two other aminohydroxamic acids, aspartic-- and glutamic--hydroxamic acid, has been determined by the same techniques used with the -aminohydroxamic acids. The two ligands have a carboxylic group in the structure and show comparable biological activities. Formation constants were calculated in different ligand-to-metal molar ratios and the coordination types were proposed. An almost constant value of the 51V NMR signal in neutral medium can be attributing to two (1:1 and 2:1 ligand-tometal ratios) similar structures, both of which can be either protonated or deprotonated. With these ligands an analogous complexation behavior at physiological conditions was found despite the presence of two or three methylenic groups between the amino and hydroxamate groups. The carboxylic groups are quite distant from the hydroxamic groups and are not involved directly in the coordination process. Therefore the coordination structures are related to that found in the vanadium(V)--alaninehydroxamic acid complex, where there is not a carboxylic group. The study of the tungsten (VI) interaction with acetohydroxamic (aha) and benzohydroxamic (bha) acids was done by potentiometric and spectrophotometric (UV ) titrations. Both ligands form similar species, however the complex formed with aha is more stable than the one formed with bha. The species formed from acetohydroxamic acid and WO42- (tungstate ion) are a monomer WO4LH3 (also formed from benzohydroxamic acid) and a series of dimeric species with different degrees of protonation: bha system - (WO4)2L2H2, (WO4)2L2H3, and (WO4)2L2H4, aha system: (WO4)2L2H3, (WO4)2L2H4 and (WO4)2L2H5. === A atividade biologica e farmacologica apresentada pelos acidos hidroxamicos e seus derivados, os quais podem atuar como antibioticos, inibidores tumorais e inibidores de divisao celular, alem da atividade insulinomimetica recentemente estudada, associada a capacidade de coordenar varios ions metalicos, tem despertado grande interesse nos ultimos anos. Compostos contendo vanadio(V) ou tungstenio(VI) foram caracterizados como insulino-mimeticos, porem a aplicacao direta dos sais destes elementos nao e muito favoravel, pois alem de serem considerados toxicos, nessa forma ficam expostos as variacoes de pH e reacoes de redox, diminuindo a acao farmacologica, principalmente quando almeja-se um substituto oral para a insulina. A especiacao completa da complexacao de vanadio(V) nos sistemas formados com o acido glicinohidroxamico e outros tres acidos -aminohidroxamicos (-alanino-, -treonino- and -lisino-) foi conseguida atraves de tecnicas potenciometrica e espectroscopicas. As constantes de formacao foram calculadas variando-se as concentracoes e as relacoes ligante para metal. Para cada ligante, dois complexos foram identificados em meio neutro com relacao metal:ligante 1:1 e 1:2. Esses complexos podem ser protonados ou desprotonados dependendo da acidez ou basicidade do meio. Estruturas para essas especies foram propostas com base nos resultados das medidas de RMN de 51V. O complexo 1:1 VO2L (VO2 + =ion dioxovanadio(V) e L-= acido - amino-hidroxamico), tem uma estrutura trigonal bipiramidal distorcida em meio neutro e existe como VO2HL+ em meio acido e como VO2(OH)L- em meio alcalino. O complexo 1:2 VO2H2L2 + formado em meio neutro tem uma estrutura octaedrica e existe tambem como VO2H3L2 2+ e VO2HL2 +, em meio acido e basico, respectivamente. Em todas essas especies apenas o grupo hidroxamico parece estar coordenado ao grupo VO2 +. Procurando explorar as diferentes possibilidades de coordenacao possiveis para estes acidos amino-hidroxamicos, a complexacao de vanadio(V) com dois acidos amino-hidroxamicos, os acidos aspartico--hidroxamico e glutamico--hidroxamico, foi investigada usando as mesmas tecnicas. Esses dois ligantes possuem um grupo carboxilico na molecula e mostram atividade biologica comparavel e superior a dos acidos -amino-hidroxamicos. Como anteriormente, esses ligantes apresentam um valor quase constante para os deslocamentos quimicos de RMN de 51V em meio neutro, que podem ser atribuidos a duas estruturas semelhantes para os complexos 1:1 e 1:2 metal:ligante, as quais podem ser protonadas ou desprotonadas. Embora exista nesses ligantes uma diferenca no numero de grupos metilenicos entre o grupo aminico e o hidroxamico, eles mostram um comportamento similar. Os grupos carboxilicos estao distantes do grupo hidroxamico e nao estao envolvidos diretamente no processo de coordenacao. As estruturas de coordenacao sao, portanto, semelhantes aquelas encontradas para os complexos de vanadio(V) com o acido -alaninohidroxamico, que nao possui o grupo carboxilico. No estudo dos sistemas contendo tungstenio (VI) e acido aceto-hidroxamico ou benzo-hidroxamico, feito atraves de titulacoes potenciometricas e espectrofotometricas na regiao do ultravioleta foi observado que os dois ligantes formam especies similares e que as formadas com o acido acetohidroxamico sao mais estaveis. Com o acido aceto-hidroxamico e o ion tunsgtato (WO42-) foi encontrada a especie monomerica WO4LH3 (encontrada tambem com o acido benzo-hidroxamico). Especies dimericas com diferentes protonacoes foram tambem identificadas: para o acido benzo-hidroxamico, (WO4)2L2H2, (WO4)2L2H3, (WO4)2L2H4 e para o acido aceto-hidroxamico: (WO4)2L2H3, (WO4)2L2H4, (WO4)2L2H5.